World's Best Scientists 2026 revealed!
Pharmacogenomics
H-index 16

Pharmacogenomics

1462-2416

Published by: Future Science Group

https://www.futuremedicine.com/journal/pgs

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Genetics 115 20 20 7
Medicine 1893 80 58 13

Additional Metrics

Number of Best Scientists*: 152
Documents by Best Scientists*: 108
Top 100 Ranked Scientists*: 1
SCIMAGO H-index: 103
SCIMAGO SJR: 0.516
Impact Factor: 1.9

Overview

Top Research Topics at Pharmacogenomics?

Pharmacogenomics generally zeroes in on subjects such as Pharmacogenetics, Pharmacology, Pharmacogenomics, Internal medicine and Bioinformatics. The study of Pharmacogenetics, which falls within the realm of Genetics, was the main focus of the presentations. Presentations on Genetics include those discussing Allele, Gene, Haplotype, Allele frequency and Genetic association.

Topics in Pharmacology were tackled in line with various other fields like CYP2C9 and Warfarin. It focuses on Pharmacogenomics but the discussions also offer insight into other areas such as MEDLINE, Drug development, Intensive care medicine, Personalized medicine and Computational biology. It explores topics in Internal medicine which can be helpful for research in disciplines like Endocrinology, Oncology, Gastroenterology and Single-nucleotide polymorphism, Genotype.

In addition to Oncology research, it aims to explore topics under Breast cancer and Chemotherapy. The main emphasis of Pharmacogenomics is the subject of Single-nucleotide polymorphism, focusing on SNP. Bioinformatics research featured in Pharmacogenomics incorporates concerns from various other topics such as Genome-wide association study, Disease and Genomics.

  • Pharmacogenetics (34.92%)
  • Pharmacology (30.10%)
  • Pharmacogenomics (28.06%)

What are the most cited papers published in the journal?

  • ABC multidrug transporters: structure, function and role in chemoresistance (740 citations)
  • CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants. (637 citations)
  • High-resolution DNA melting analysis for simple and efficient molecular diagnostics (551 citations)

Research areas of the most cited articles at Pharmacogenomics:

The published articles cover a variety of subjects, including Pharmacogenetics, Pharmacology, Genetics, Pharmacogenomics and Internal medicine. The journal articles hold forums on Pharmacogenetics that merge themes from other disciplines such as CYP2C19, Warfarin, Immunology and Bioinformatics. The most cited papers focus on Internal medicine but the discussions also offer insight into other areas such as Gastroenterology, Endocrinology, Oncology and Genotype.

What topics the last edition of the journal is best known for?

  • Internal medicine
  • Gene
  • Cancer

The previous edition focused in particular on these issues:

The scientific interests tackled in Pharmacogenomics are Pharmacogenetics, Internal medicine, Pharmacogenomics, Bioinformatics and Genotype. Topics in Pharmacogenetics explored in it were investigated in conjunction with research in Pharmacokinetics, Adverse effect, CYP2D6, Computational biology and Candidate gene. The Pharmacokinetics study featured falls within the wider field of Pharmacology.

While the journal focused on Internal medicine, it was also able to explore topics like Polymorphism (computer science), Oncology, Gastroenterology, Genotyping and Single-nucleotide polymorphism. The concepts on Pharmacogenomics presented in Pharmacogenomics can also apply to other research fields, including Precision medicine, Health care, Medical education, Personalized medicine and Disease. The research on Bioinformatics featured in it combines topics in other fields like Lamotrigine, Analgesic, Rheumatoid arthritis and Genetic marker.

The most cited articles from the last journal are:

  • Providers' perspectives on the clinical utility of pharmacogenomic testing in pediatric patients. (4 citations)
  • Integrating pharmacogenetic testing via medication therapy management in an outpatient family medicine clinic. (3 citations)
  • KRAS-targeted therapies in advanced solid cancers: drug the undruggable? (2 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Pharmacogenomics (based on the number of publications) are:

  • Howard L. McLeod (53 papers) published 1 paper at the last edition the same number as at the previous edition,
  • Ron H.N. van Schaik (41 papers) absent at the last edition,
  • George P. Patrinos (34 papers) published 3 papers at the last edition the same number as at the previous edition,
  • Adrián LLerena (33 papers) published 1 paper at the last edition the same number as at the previous edition,
  • Henk-Jan Guchelaar (30 papers) published 1 paper at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Pharmacogenomics (based on the number of publications) are:

  • University of North Carolina at Chapel Hill (68 papers) published 2 papers at the last edition the same number as at the previous edition,
  • Erasmus University Rotterdam (60 papers) absent at the last edition,
  • Duke University (49 papers) published 1 paper at the last edition, 1 less than at the previous edition,
  • Mayo Clinic (48 papers) published 3 papers at the last edition, 4 less than at the previous edition,
  • Utrecht University (47 papers) absent at the last edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 6.25% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 12.22% were posted by at least one author from the top 10 institutions publishing in the journal. Another 12.22% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 18.89% of all publications and 56.67% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Top Publications

  • Precision medicine in interventional cardiology: implications for antiplatelet therapy in patients undergoing percutaneous coronary intervention.

    (2022)
    51 Citations
  • Clinical implementation of pharmacogenomics via a health system-wide research biobank: the University of Colorado experience.

    Christina L. Aquilante;Christina L. Aquilante;David P. Kao;Katy E. Trinkley;Katy E. Trinkley;Chen Tan Lin;Chen Tan Lin

    (2020)
    46 Citations
  • Is there a future for CYP1A2 pharmacogenetics in the optimal dosing of clozapine

    Can-Jun Ruan;Jose de Leon;Jose de Leon;Jose de Leon

    (2020)
    37 Citations
  • Pharmacoresponse in genetic generalized epilepsy: a genome-wide association study.

    Stefan Wolking;Stefan Wolking;Herbert Schulz;Anne A.T. Nies;Anne A.T. Nies;Mark McCormack

    (2020)
    29 Citations
  • Assessment of primary care practitioners' attitudes and interest in pharmacogenomic testing.

    D Max Smith;D Max Smith;Tarlan Namvar;Ryan P Brown;T Blaise Springfield

    (2020)
    29 Citations
  • Pharmacogenomic testing to support prescribing in primary care: a structured review of implementation models.

    Judith Hayward;John McDermott;Nadeem Qureshi;William Newman;William Newman

    (2021)
    27 Citations
  • Pharmacogenomics in the UK National Health Service: Opportunities and challenges

    Richard M Turner;William G Newman;Elvira Bramon;Christine J McNamee

    (2020)
    20 Citations
  • OPRM1 and COMT polymorphisms: implications on postoperative acute, chronic and experimental pain after cardiac surgery.

    Maja Matic;Sjoerd de Hoogd;Saskia N de Wildt;Saskia N de Wildt;Dick Tibboel

    (2020)
    19 Citations

Related Online Degrees & Career Pathways

For those interested in expanding their education and career options beyond traditional medical degrees, several related online programs offer valuable pathways. An online exercise science degree provides a strong foundation in human physiology and physical fitness, ideal for careers in rehabilitation, sports training, or wellness coaching.

Similarly, a kinesiology online degree focuses on the mechanics of body movement, often bridging the gap between medicine, physical therapy, and athletic performance. These programs are popular for those aiming to work in clinical or research settings related to human motion.

For healthcare professionals considering specialization, an important option is exploring nursing roles through targeted certifications. Programs such as pmhnp online programs prepare nurses to become psychiatric-mental health nurse practitioners, addressing critical mental health needs in clinical practice.

Additionally, nurses looking to advance their qualifications can consider the cheapest post master's fnp program, which offers a cost-effective way to become a family nurse practitioner. These specialized pathways complement medical education and open doors to diverse, rewarding careers in healthcare.

Best Scientists Contributing to This Journal